Latest publications

sample

Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?

AbstractBackground: We evaluated the value of pre-treatment positron-emission tomography-computed tomography...

Posted by : Mme. Julie HENRIQUES, Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Cancers (Basel)

sample

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

AbstractBackground: Histological characteristics at the invasive front may reflect tumor aggressiveness;...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Annals of oncology

sample

%TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

AbstractBackground and objective: Longitudinal analysis of patient-reported outcome (PRO) data remains challenging,...

Posted by : Mr. Antoine FALCOZ
Journal name : Comput Methods Programs Biomed

sample

Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review

AbstractAim: A systematic literature review of immuno-oncology trials was conducted to assess the potential impact of...

Posted by : Mr. Antoine FALCOZ, Dr. Guillaume MOUILLET
Journal name : Qual Life Res

sample

Feasibility of health‑related quality of life (HRQoL) assessment for cancer patients using electronic patient‑reported outcome (ePRO) in daily clinical practice

AbstractIntroduction - Routine Electronic Monitoring of Health-Related Quality of Life (HRQoL) (REMOQOL) in clinical...

Posted by : Dr. Guillaume MOUILLET, Mr. Antoine FALCOZ, Mme. Joëlle FRITZSCH, , Mme. Oumelkheir DJOUMAKH, Dr. Sophie PAGET-BAILLY
Journal name : Quality of Life Research

11 2020, November

Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients

AbstractBackground: Randomized controlled trials (RCTs) represent the best evidence in oncology research....

Posted by : Mr. Antoine FALCOZ, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY
Journal name : Neurooncol Pract

sample

Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)

AbstractPatients and methods: A post hoc analysis of all pathologic reports from patients with stage III CC...

Posted by : Mme. Julie HENRIQUES, Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : J Clin Oncol

2015-2022 © Copyright - UMQVC.org

↑

Website by Pearlweb